In the U.S. there are about 400,000 hospital admissions for AF generating $6 billion is medical expenditures. Ott said it’s important that AF be treated because it can cause strokes and heart failure. He explained that coumadin/warfarin is an anti-arrhythmic drug. As an anticoagulant or blood thinner it helps reduce formation of blood clots and can help maintain a regular rhythm.
Electrical cardioversion, or shocking the heart back to normal, and a procedure called “nodal catheter ablation” are other options.
“Catheter ablation eliminates fast and irregular heart rates. It’s for those not responding to drugs and it helps reduce doctor and hospital visits.
“This procedure is relatively complex. It’s for patients with very bad symptoms and frequent episodes,” Ott told the audience.
The surgery has a 90 percent success rate with about a five percent complication rate, which includes bleeding and/or a stroke.
“Of 500,000 strokes a year in the U.S. about 120,000 are due to AF. Seventy percent (of the 120,000) end up with severe nerve complications because blood clots travel to the brain,” Ott said.
For those at moderate risk and not taking coumadin/warfarin, there’s a 5 to 8 percent risk for stroke. This is in contrast to 10 to 17 percent for anyone at high risk.
However, if coumadin/warfarin is taken, the risk of stroke is lowered to 1 to 2 percent. Aspirin is prescribed only for those at low risk for stroke.
Ott said AF can be treated with medication, electrical cardioversion or nodal catheter ablation.
“The goal is always to maintain a normal heart rhythm and to prevent a stroke.”
Free Sarver Heart Center lectures are sponsored by Green Valley Recreation and are open to the public. They are held on the third Thursday of the month at Canoa Hills Social Center, 3600. S. Camino del Sol.
Ellen Sussman is a freelance writer in Green Valley. Contact her at
ellen2414@cox.net.
UPCOMING LECTURES
All lectures at 10 a.m. at Canoa Hills Social Center
Nov. 19: How You Can Prevent a Stroke
Dec. 17: Heart Disease in Women: “Apples” and “Pears”
Jan. 21: The Epidemic of Obesity and Diabetes
Feb. 18: What’s New in Heart Disease Prevention
March 18: Cutting-Edge Technology in Heart Disease Diagnosis and Treatment